Atlas Trials

Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer

Clinical trial NCT00006118 · UNKNOWN

Trial details

NCT number
NCT00006118
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
1999-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.